KORU Medical Systems Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

STOCK-BASED COMPENSATION (Tables)

STOCK-BASED COMPENSATION (Tables)

6 Months Ended

Jun. 30, 2019

Share-based Payment Arrangement [Abstract]

Schedule of fair value of the stock options granted Black-Scholes option valuation model

The risk-free interest rate was selected based upon yields of the U.S. Treasury issues with a term equal to the expected life of the option being valued.


	June 30,
	2019		2018

Dividend yield		0.00%		0.00%
Expected Volatility		58.9% - 60.3%		65.2%
Weighted-average volatility		—		—
Expected dividends		—		—
Expected term (in years)		10 Years		5 Years
Risk-free rate		2.12 - 2.72%		2.80%

Schedule of stock option plan

The following table summarizes the status of the Plan:


	Six months Ended June 30,
	2019			2018
	Shares	Weighted Average Exercise Price		Shares		Weighted Average Exercise Price

Outstanding at January 1	2,419,000	$	1.00		1,038,000	$	0.41
Granted	1,300,000	$	1.66		18,000	$	1.33
Exercised	65,000	$	0.38		125,000	$	0.41
Forfeited	—	$	—		—	$	—
Outstanding at June 30	3,654,000	$	1.24		931,000	$	0.43
Options exercisable at June 30	804,260	$	0.63		656,885	$	0.39
Weighted average fair value of options granted during the period	—	$	1.16		—	$	0.75
Stock-based compensation expense	—	$	274,731		—	$	26,670

Schedule of information pertaining to time based options outstanding

The following table presents information pertaining to options outstanding at June 30, 2019:


Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price

$0.36 - $2.09	3,654,000	5-10 years	$	1.24	804,260	$	0.63

Schedule of performance base share options

The risk-free interest rate was selected based upon yields of the U.S. Treasury issues with a term equal to the expected life of the option being valued.


	June 30,
	2019		2018

Dividend yield		0.00%		—
Expected Volatility		58.9%		—
Weighted-average volatility		—		—
Expected dividends		—		—
Expected term (in years)		10 Years		—
Risk-free rate		2.07%		—

Schedule of performance base options outstanding

The following table summarizes the status of the Plan:


	Six months Ended June 30,
	2019			2018
	Shares	Weighted Average Exercise Price		Shares		Weighted Average Exercise Price

Outstanding at January 1	—	$	—		—	$	—
Granted	1,000,000	$	1.70		—	$	—
Exercised	—	$	—		—	$	—
Forfeited	—	$	—		—	$	—
Outstanding at June 30	1,000,000	$	1.70		—	$	—
Options exercisable at June 30	—	$	—		—	$	—
Weighted average fair value of options granted during the period	—	$	1.16		—	$	—
Stock-based compensation expense	—	$	41,909		—	$	—

Schedule of information pertaining to performance base options outstanding

The following table presents information pertaining to performance based options outstanding at June 30, 2019:


Range of Exercise Price	Number Outstanding	Weighted Average Remaining Contractual Life	Weighted Average Exercise Price		Number Exercisable	Weighted Average Exercise Price

$1.70	1,000,000	10 years	$	1.70	—	$	1.70